Dr. Kobashi says that the most common symptom of bladder cancer is blood in urine. The blood can range from bright red to a ...
Trodelvy’s next big readout is EVOKE-03, which is testing the Gilead drug with Merck’s PD-1 inhibitor Keytruda in PD-L1-high ...
Aura Biosciences released early Phase 1 trial data on bel-sar for non-muscle-invasive bladder cancer, showing promising ...
To mark Breast Cancer Awareness Month, we speak to inspiring Singaporeans about their journey in battling and overcoming ...
Researchers found that DNA mutations from antiviral enzymes and chemotherapy fuel early bladder cancer, while abnormal ...
With its lead candidate in a phase 3 trial for a rare eye cancer, Aura Biosciences is looking to expand the drug into a ...
The following is a summary of “Identification and experimental validation of a sialylation–related long noncoding RNA ...
Partnering with others around the world, the researchers have been awarded £100,000 to test a non-invasive urine test for ...